Pfizer Inc. (PFE)
Pre-Market:
| Previous Close | 28.18 |
| Open | 28.24 |
| Bid | 28.07 x 4000 |
| Ask | 28.11 x 3000 |
| Day's Range | 27.92 - 28.28 |
| 52 Week Range | 25.20 - 40.37 |
| Volume | |
| Avg. Volume | 42,712,706 |
| Market Cap | 158.721B |
| Beta (5Y Monthly) | 0.58 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.05 |
| Earnings Date | Jul 30, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | 1.68 (6.00%) |
| Ex-Dividend Date | May 09, 2024 |
| 1y Target Est | 31.37 |
- Reuters
UPDATE 2-'Choose France' investment push bags record $16 billion in pledges
France won a record 15 billion euros ($16.17 billion) in foreign investment pledges on Monday, allowing President Emmanuel Macron to bask in the limelight with global CEOs and forget about strained public finances and weak polls for a while. The bumper crop of pledges, in sectors ranging from artificial intelligence to pharmaceuticals and energy, stood Macron in good stead as he hosted business leaders for the annual "Choose France" summit at Versailles Palace.
Simply Wall St.Pfizer Inc. Just Beat EPS By 61%: Here's What Analysts Think Will Happen Next
Pfizer Inc. ( NYSE:PFE ) just released its first-quarter report and things are looking bullish. It was overall a...
Barrons.comA Struggling Pfizer Looks for Help From a Wall Streeter
As the big drugmaker tries to turn its fortunes around by focusing on oncology, it has turned to a Citi analyst who hasn’t recommended the stock in over a decade. But Andrew Baum has something Pfizer needs: oncology expertise.
